Literature DB >> 25073815

Deaths: preliminary data for 2009.

Kenneth D Kochanek, Jiaquan Xu, Sherry L Murphy, Arialdi M Miniño, Hsiang-Ching Kung.   

Abstract

Objectives-This report presents preliminary U.S. data on deaths, death rates, life expectancy, leading causes of death, and infant mortality for 2009 by selected characteristics such as age, sex, race, and Hispanic origin. Methods-Data in this report are based on death records comprising more than 96 percent of the demographic and medical files for all deaths in the United States in 2009. The records are weighted to independent control counts for 2009. Comparisons are made with 2008 preliminary data. Results-The age-adjusted death rate decreased from 758.7 deaths per 100,000 population in 2008 to 741.0 deaths per 100,000 population in 2009. From 2008 to 2009, age-adjusted death rates decreased significantly for 10 of the 15 leading causes of death: Diseases of heart, Malignant neoplasms, Chronic lower respiratory diseases, Cerebrovascular diseases, Accidents (unintentional injuries), Alzheimer's disease, Diabetes mellitus, Influenza and pneumonia, Septicemia, and Assault (homicide). Life expectancy increased by 0.2 year, from 78.0 in 2008 to 78.2 in 2009. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Year:  2011        PMID: 25073815

Source DB:  PubMed          Journal:  Natl Vital Stat Rep        ISSN: 1551-8922


  139 in total

1.  The contemporary approach to ischemic brain injury: applying existing knowledge of circulation, temperature, and glucose management to improve clinical outcomes.

Authors:  William L Lanier; Jeffrey J Pasternak
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

2.  Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span.

Authors:  Stacy L Andersen; Paola Sebastiani; Daniel A Dworkis; Lori Feldman; Thomas T Perls
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-01-04       Impact factor: 6.053

3.  The Hispanic paradox unraveled?

Authors:  M Bradley Drummond
Journal:  Am J Respir Crit Care Med       Date:  2011-12-01       Impact factor: 21.405

4.  Influenza update: a review of currently available vaccines.

Authors:  Lisa R Clayville
Journal:  P T       Date:  2011-10

5.  Alcohol use predicts ER visits in individuals with alpha-1 antitrypsin deficiency (AATD) associated COPD.

Authors:  Karin F Hoth; Dee W Ford; Robert A Sandhaus; Charlie Strange; Frederick S Wamboldt; Kristen E Holm
Journal:  COPD       Date:  2012-05-31       Impact factor: 2.409

6.  Management of metabolic effects associated with anticancer agents targeting the PI3K-Akt-mTOR pathway.

Authors:  Naifa L Busaidy; Azeez Farooki; Afshin Dowlati; John P Perentesis; Janet E Dancey; Laurence A Doyle; Joanna M Brell; Lillian L Siu
Journal:  J Clin Oncol       Date:  2012-07-09       Impact factor: 44.544

7.  Adjunctive therapy with inhaled nitric oxide for severe acute chest syndrome in patients with sickle cell disease.

Authors:  Hermann Wrigge; Eduardo L V Costa; Thilo Busch
Journal:  Intensive Care Med       Date:  2015-10-02       Impact factor: 17.440

8.  Methods needed to measure predictive accuracy: A study of diabetic patients.

Authors:  Hafiz M R Khan; Sarah Mende; Aamrin Rafiq; Kemesha Gabbidon; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-11       Impact factor: 5.187

9.  Type and cause of liver disease in Korea: single-center experience, 2005-2010.

Authors:  Sang Soo Lee; Young-Sang Byoun; Sook-Hyang Jeong; Yeo Myung Kim; Ho Gil; Bo-Young Min; Mun Hyuk Seong; Eun Sun Jang; Jin-Wook Kim
Journal:  Clin Mol Hepatol       Date:  2012-09-25

10.  A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfa.

Authors:  Carlos G Guardia; Fernando R Moya; Sunil Sinha; Phillip D Simmons; Robert Segal; Jay S Greenspan
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.